A detailed history of Rice Hall James & Associates, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 1,690 shares of LLY stock, worth $1.26 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,690
Previous 1,840 8.15%
Holding current value
$1.26 Million
Previous $1.67 Million 10.09%
% of portfolio
0.09%
Previous 0.11%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$772.14 - $960.02 $115,821 - $144,003
-150 Reduced 8.15%
1,690 $1.5 Million
Q1 2024

Apr 23, 2024

SELL
$592.2 - $792.28 $29,610 - $39,614
-50 Reduced 2.65%
1,840 $1.43 Million
Q3 2023

Nov 02, 2023

SELL
$434.7 - $599.3 $21,735 - $29,964
-50 Reduced 2.58%
1,890 $1.02 Million
Q2 2023

Jul 24, 2023

SELL
$350.74 - $468.98 $17,537 - $23,449
-50 Reduced 2.51%
1,940 $909,000
Q1 2023

May 11, 2023

SELL
$310.63 - $364.82 $46,594 - $54,723
-150 Reduced 7.01%
1,990 $683,000
Q2 2022

Aug 08, 2022

SELL
$278.73 - $327.27 $41,809 - $49,090
-150 Reduced 6.55%
2,140 $694,000
Q1 2022

May 05, 2022

SELL
$234.69 - $291.66 $23,469 - $29,166
-100 Reduced 4.18%
2,290 $656,000
Q2 2021

Jul 29, 2021

SELL
$180.55 - $233.54 $18,055 - $23,354
-100 Reduced 4.02%
2,390 $549,000
Q2 2018

Aug 02, 2018

BUY
$75.7 - $86.88 $188,493 - $216,331
2,490 New
2,490 $212,000
Q1 2018

Apr 25, 2018

SELL
$74.21 - $87.6 $184,782 - $218,124
-2,490 Closed
0 $0
Q3 2017

Oct 30, 2017

BUY
$77.07 - $85.54 $191,904 - $212,994
2,490
2,490 $213,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Rice Hall James & Associates, LLC Portfolio

Follow Rice Hall James & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.